Shield Pharmaceuticals Corp. Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Shield Pharmaceuticals Corp. Pharmaceutical Import Records from India — 2 Products, $387.3K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Shield Pharmaceuticals Corp. — Pharmaceutical Importer Profile (2026) | 2 Products, $387.3K Trade | TransData Nexus

Shield Pharmaceuticals Corp.

Pharmaceutical Importer · United States · Respiratory & OTC Focus · $387.3K Total Trade · DGFT Verified

Shield Pharmaceuticals Corp. is a pharmaceutical importer based in United States with a total trade value of $387.3K across 2 products in 2 therapeutic categories. Based on 39 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Shield Pharmaceuticals Corp. sources from 3 verified Indian suppliers, with Alder Biochem Private Limited accounting for 76.7% of imports.

Shield Pharmaceuticals Corp. — Import Portfolio & Supplier Network

Shield Pharmaceuticals Corp. import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Shield Pharmaceuticals Corp.?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Alder Biochem Private Limited	$621.2K	63	76.7%
Cubit Lifesciences Llp	$145.2K	22	17.9%
Medinomics Health Care Private Limited	$43.8K	2

What Formulations Does Shield Pharmaceuticals Corp. Import?

Formulation	Value	Ships
Bismuth subsalicylate 262MG soft gelatincapsules,batch no.p519301,mfg dt. 02/2025, exp.dt.	$27.0K	2
Bismuth subsalicylate 262MG soft gelatincapsules,batch no.p519302,mfg dt. 02/2025, exp.dt.	$27.0K	2
Acetaminophen 500MG soft gelatin capsules, batch no. p519203, mfg. dt. 02/2025,exp. dt.	$23.4K	2
Acetaminophen 325 MG,,dextromethorphan hbr 10 MG phenylephrine hcl 5 MG capsules(1045800 CAPS)	$21.9K	1
Acetaminophen 325 MG,,dextromethorphan hbr 15 MG d.oxylamine succinate 6.25MG capsules (1045800 CAPS)	$21.9K	1
Diphenhydramine hcl 25MG soft gelatin capsules (dyefree) (batch no. p518701) (mfg . dt. 02/2025 & exp. dt. 01/2027)	$20.3K	1
Diphenyhydramine hcl 25MG, batch no. ef124010,mfg. dt. dec-24, exp.dt.	$20.2K	3
Diphenyhydramine hcl 25MG, batch no. ef125001,mfg. dt. jan-25, exp.dt.	$20.2K	3
Diphenyhydramine hcl 25MG, batch no. ef124011,mfg. dt. dec-24, exp.dt.	$20.2K	3
Diphenyhydramine hcl 25MG, batch no. ef124009,mfg. dt. dec-24, exp.dt.	$19.9K	3
Dextromethorphan hbr 15MG soft gelatin capsules (batch no. p518604) (mfg . dt. 02/2025 & exp. dt. 01/2027)	$19.2K	1
Dextromethorphan hbr 15MG soft gelatin capsules (batch no. p518601) (mfg . dt. 02/2025 & exp. dt. 01/2027)	$19.0K	1
Dextromethorphan hbr 15MG soft gelatin capsules (batch no. p518602) (mfg . dt. 02/2025 & exp. dt. 01/2027)	$19.0K	1
Dextromethorphan hbr 15MG soft gelatin capsules (batch no. p518603) (mfg . dt. 02/2025 & exp. dt. 01/2027)	$19.0K	1
Docusate sodium 50MG, sennosides 8.6MG soft gelatin capsules (batch no. p519701)(mfg . dt. 03/2025 & exp. dt. 02/2027)	$17.0K	1

Shield Pharmaceuticals Corp. imports 75 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Dextromethorphan	Respiratory & OTC	$298.5K	32	2.0%	6
2	Docusate	Gastrointestinal	$88.8K	7	1.0%	15

Shield Pharmaceuticals Corp. imports 2 pharmaceutical products across 2 categories into United States totaling $387.3K.

Shield Pharmaceuticals Corp. — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Shield Pharmaceuticals Corp. is a U.S.-based pharmaceutical importer specializing in the acquisition of finished pharmaceutical formulations from international suppliers, particularly from India. The company is headquartered at 100 Raynor Ave, Suite 3, Ronkonkoma, NY 11779. As a pharmaceutical buyer, Shield Pharmaceuticals Corp. plays a pivotal role in the U.S. pharmaceutical distribution network by sourcing and importing finished dosage forms, including tablets, capsules, syrups, and injections, thereby contributing to the diversity and availability of pharmaceutical products in the U.S. market.

2Distribution Network

While specific details regarding Shield Pharmaceuticals Corp.'s warehouse locations and logistics capabilities are not publicly disclosed, the company's operations are likely supported by a network of distribution centers strategically located to facilitate efficient nationwide delivery. Given its role as an importer, Shield Pharmaceuticals Corp. collaborates with various logistics partners to ensure timely and compliant distribution of pharmaceutical products across the United States.

3Industry Role

In the U.S. pharmaceutical supply chain, Shield Pharmaceuticals Corp. functions primarily as a pharmaceutical importer and distributor. By sourcing finished pharmaceutical formulations from international suppliers, particularly from India, the company enhances the diversity and availability of pharmaceutical products in the U.S. market. This role is crucial in meeting the demand for various therapeutic categories and ensuring a steady supply of medications to healthcare providers and patients.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Shield Pharmaceuticals Corp.

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Shield Pharmaceuticals Corp. demonstrates a high degree of supplier concentration, with 76.7% of its imports sourced from ALDER BIOCHEM PRIVATE LIMITED, 17.9% from CUBIT LIFESCIENCES LLP, and 5.4% from MEDINOMICS HEALTH CARE PRIVATE LIMITED. This concentration indicates a strategic choice to maintain strong, stable relationships with a select group of suppliers, potentially ensuring consistent product quality and supply reliability. However, such dependency also poses risks; any disruptions with these key suppliers could significantly impact Shield Pharmaceuticals Corp.'s ability to meet market demand. The company's focus on a limited number of suppliers suggests a deliberate strategy to leverage established partnerships, but it also underscores the importance of managing supplier relationships to mitigate potential risks.

2Supply Chain Resilience

The resilience of Shield Pharmaceuticals Corp.'s supply chain is closely tied to the stability and reliability of its key Indian suppliers. The company's reliance on a small number of suppliers may limit its ability to diversify sourcing options in response to supply chain disruptions. Additionally, the exposure to specific shipping routes and potential regulatory changes in India could impact the supply chain's stability. Ensuring that suppliers adhere to Good Manufacturing Practices (GMP) and maintaining compliance with U.S. Food and Drug Administration (FDA) regulations are critical to mitigating risks associated with product quality and supply continuity.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation and distribution of pharmaceutical products. The FDA enforces the Federal Food, Drug, and Cosmetic Act (FD&C Act), which sets forth requirements for the safety, efficacy, and quality of drugs imported into the U.S. Pharmaceutical importers must ensure that their products comply with FDA regulations, including those related to manufacturing practices, labeling, and marketing authorization. The FDA's role is to protect public health by ensuring that all drugs, including those imported from countries like India, meet U.S. standards.

2Import Licensing & GMP

Importers of pharmaceutical products into the United States must obtain appropriate import licenses and ensure that their products are manufactured in facilities compliant with Good Manufacturing Practices (GMP). The FDA recognizes GMP certifications from various international standards, including EU GMP, WHO GMP, and PIC/S. These certifications are essential for demonstrating that manufacturing processes meet the FDA's stringent quality standards. Additionally, importers must secure wholesale distribution authorizations to legally distribute pharmaceutical products within the U.S. market. Compliance with these requirements is crucial for maintaining the integrity of the pharmaceutical supply chain and ensuring patient safety.

Shield Pharmaceuticals Corp. — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Shield Pharmaceuticals Corp. focuses on importing pharmaceutical products in the respiratory and over-the-counter (OTC) categories, accounting for 77.1% of its imports, and the gastrointestinal category, comprising 22.9%. This strategic focus aligns with market demand for treatments in these therapeutic areas, addressing prevalent health concerns among the U.S. population. The company's emphasis on these categories suggests a targeted approach to meet specific consumer needs and capitalize on market opportunities within these segments.

2Sourcing Profile

Shield Pharmaceuticals Corp. primarily sources generic drug formulations from India, leveraging the country's robust pharmaceutical manufacturing capabilities. The company's preference for finished pharmaceutical formulations indicates a strategy to provide ready-to-market products, ensuring faster availability to U.S. consumers. India's established reputation for producing high-quality generics makes it a strategic partner for Shield Pharmaceuticals Corp. in fulfilling its procurement needs.

3Market Positioning

Based on its product mix, Shield Pharmaceuticals Corp. serves the U.S. retail pharmacy segment, supplying a range of pharmaceutical products that are readily available to consumers without the need for a prescription. The company's focus on OTC products positions it to meet the demands of the retail market, providing accessible healthcare solutions to a broad consumer base.

Seller's Guide — How to Become a Supplier to Shield Pharmaceuticals Corp.

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the U.S. market by meeting the quality and regulatory standards required by the FDA. Shield Pharmaceuticals Corp.'s current sourcing pattern, characterized by a concentrated supplier base, suggests potential gaps that new suppliers could fill, particularly if they can offer competitive pricing, consistent product quality, and reliable supply chains. Establishing relationships with Shield Pharmaceuticals Corp. could provide Indian exporters with a foothold in the U.S. market, especially if they can demonstrate compliance with FDA regulations and a commitment to quality.

2Requirements & Qualifications

Indian exporters seeking to supply Shield Pharmaceuticals Corp. and the U.S. market must obtain FDA approval for their products, ensuring compliance with U.S. regulations. Manufacturing facilities must adhere to GMP standards recognized by the FDA, such as EU GMP, WHO GMP, or PIC/S certifications. Additionally, products must meet FDA labeling requirements, including accurate and comprehensive information in English. Compliance with these standards is essential for entering and maintaining a presence in the U.S. pharmaceutical market.

How to Approach

Frequently Asked Questions — Shield Pharmaceuticals Corp.

What products does Shield Pharmaceuticals Corp. import from India?

Shield Pharmaceuticals Corp. imports 2 pharmaceutical products across 2 categories. Top imports: Dextromethorphan ($298.5K), Docusate ($88.8K).

Who supplies pharmaceuticals to Shield Pharmaceuticals Corp. from India?

Shield Pharmaceuticals Corp. sources from 3 verified Indian suppliers. The primary supplier is Alder Biochem Private Limited (76.7% of imports, $621.2K).

What is Shield Pharmaceuticals Corp.'s total pharmaceutical import value?

Shield Pharmaceuticals Corp.'s total pharmaceutical import value from India is $387.3K, based on 39 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Shield Pharmaceuticals Corp. focus on?

Shield Pharmaceuticals Corp. imports across 2 categories. The largest: Respiratory & OTC (77.1%), Gastrointestinal (22.9%).

Get Full Shield Pharmaceuticals Corp. Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.